Nota Bene Cancer
Nota Bene Cancer est un bulletin hebdomadaire de veille bibliographique. En libre accès, Nota Bene Cancer permet à ses abonnés de gagner du temps pour se tenir informé de l’actualité scientifique et médicale dans les divers domaines de la recherche sur les cancers.
Rechercher des publications
Pour retrouver les publications signalées par Nota Bene Cancer (archives indexées à partir du n°127 du 1" mars 2012) :
Sommaire du n° 536 du 12 septembre 2022
Qualité de vie, soins de support (4)
Menée en Espagne à partir de données portant sur 1 862 patients ayant survécu à un cancer à haut risque de récidive, cette étude analyse les facteurs sociodémographiques et médicaux liés à leur qualité de vie
Quality of life in cancer survivorship: Sociodemographic and disease-related moderators
Menée en Espagne à partir de données portant sur 1 862 patients ayant survécu à un cancer à haut risque de récidive, cette étude analyse les facteurs sociodémographiques et médicaux liés à leur qualité de vie
Quality of life in cancer survivorship: Sociodemographic and disease-related moderators
Andreu, Yolanda ; Martínez, Paula ; Soto-Rubio, Ana ; Pérez-Marín, Marián ; Cervantes, Andres ; Arribas, Leoncio
Rationale : To identify high-risk survivors in order to provide appropriate care. Purpose : To analyse the quality of life (QOL) of cancer survivors using an instrument designed specifically for this population and considering different sociodemographic and disease-related characteristics as possible modulating variables. Methods : The Quality of Life in Adult Cancer Survivors (QLACS) was filled out by a large and heterogeneous sample of disease-free post-treatment Spanish cancer survivors [...]
Menée aux Etats-Unis à partir de données portant sur 8 969 patients ayant survécu à un cancer pédiatrique (âge moyen : 13,7 ans) et sur 44 845 témoins, cette étude de cohorte analyse les effets des recommandations 2016 des "Centers for Disease Control and Prevention" relatives aux prescriptions d'opioïdes sur un mauvais usage potentiel et sur la survenue de troubles liés à l'utilisation d'autres substances
Changes in Opioid Prescriptions and Potential Misuse and Substance Use Disorders Among Childhood Cancer Survivors Following the 2016 Opioid Prescri...
Menée aux Etats-Unis à partir de données portant sur 8 969 patients ayant survécu à un cancer pédiatrique (âge moyen : 13,7 ans) et sur 44 845 témoins, cette étude de cohorte analyse les effets des recommandations 2016 des "Centers for Disease Control and Prevention" relatives aux prescriptions d'opioïdes sur un mauvais usage potentiel et sur la survenue de troubles liés à l'utilisation d'autres substances
Changes in Opioid Prescriptions and Potential Misuse and Substance Use Disorders Among Childhood Cancer Survivors Following the 2016 Opioid Prescribing Guideline
Hu, Xin ; Brock, Katharine E. ; Effinger, Karen E. ; Zhang, Bo ; Graetz, Ilana ; Lipscomb, Joseph ; Ji, Xu
Importance :The Centers for Disease Control and Prevention (CDC) released an opioid-prescribing guideline in March 2016. Little is known about the guideline’s potential effects on childhood cancer survivors, a population at high risk for pain. Objective : To examine changes in opioid prescriptions and potential misuse/substance use disorders (SUD) among childhood cancer survivors and peers without cancer following the guideline release. Design, Setting, and Participants : In this cohort study [...]
Mené aux Etats-Unis sur 128 patients atteints d'un cancer, cet essai randomisé évalue l'effet de hautes doses de dexaméthasone sur l'intensité d'une dyspnée liée à la maladie
Effect of dexamethasone on dyspnoea in patients with cancer (ABCD): a parallel-group, double-blind, randomised, controlled trial
Mené aux Etats-Unis sur 128 patients atteints d'un cancer, cet essai randomisé évalue l'effet de hautes doses de dexaméthasone sur l'intensité d'une dyspnée liée à la maladie
Effect of dexamethasone on dyspnoea in patients with cancer (ABCD): a parallel-group, double-blind, randomised, controlled trial
Hui, David ; Puac, Veronica ; Shelal, Zeena ; Dev, Rony ; Hanneman, Sandra K. ; Jennings, Kristofer ; Ma, Hilary ; Urbauer, Diana L. ; Shete, Sanjay ; Fossella, Frank ; Liao, Zhongxing ; Blumenschein, George, Jr. ; Chang, Joe Y. ; O'Reilly, Michael ; Gandhi, Saumil J. ; Tsao, Anne ; Mahler, Donald A. ; Bruera, Eduardo
Background : Systemic corticosteroids are commonly prescribed for palliation of dyspnoea in patients with cancer, despite scarce evidence to support their use. We aimed to assess the effect of high-dose dexamethasone versus placebo on cancer-related dyspnoea. Methods :The parallel-group, double-blind, randomised, controlled ABCD (Alleviating Breathlessness in Cancer Patients with Dexamethasone) trial was done at the at the University of Texas MD Anderson Cancer Center and the general oncology [...]
Menée en Chine par questionnaire auprès de 410 patientes ayant survécu à un cancer du sein, cette étude transversale analyse la présence et la sévérité de douleurs articulaires en lien avec des traitements par inhibiteurs de l'aromatase
Prevalence and correlates of joint pain among Chinese breast cancer survivors receiving aromatase inhibitor treatment
Menée en Chine par questionnaire auprès de 410 patientes ayant survécu à un cancer du sein, cette étude transversale analyse la présence et la sévérité de douleurs articulaires en lien avec des traitements par inhibiteurs de l'aromatase
Prevalence and correlates of joint pain among Chinese breast cancer survivors receiving aromatase inhibitor treatment
Wang, Tao ; Huang, Yu-Yan ; Liu, Xian-Liang ; Molassiotis, Alex ; Yao, Li-Qun ; Zheng, Si-Lin ; Tan, Jing-Yu ; Huang, Hou-Qiang
Background : Aromatase inhibitor (AI)-induced joint pain is a common toxicity of AI treatment. Although many studies have been conducted to examine the occurrence and severity of AI-induced joint pain in breast cancer survivors, none of the studies focused on the Chinese population with breast cancer. Given that the differences in cultural background and the genetic structure between Asians and Caucasians may contribute to different phenotypes of joint pain, this cross-sectional study was [...]
Observation (4)
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
COVID-19 vaccine-related adverse events in solid cancer patients treated with immunotherapy
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
COVID-19 vaccine-related adverse events in solid cancer patients treated with immunotherapy
Bouleftour, Wafa ; Bonjean, Paul ; Grangeon, Kevin ; Magne, Nicolas
Abstract:Little data are available regarding the effects of COVID-19 vaccine in cancer patients undergoing immunotherapy. Thereby, COVID-19 vaccine-related adverse events were monitored through a short questionnaire in solid cancer patients receiving immunotherapy.A total of 95 patients were included in this study. Two doses of vaccines were administered to cancer patients which mainly received Pembrolizumab (51.1%). Respectively 78.2% and 62.2% of patients reported no adverse events after the [...]
The putative mechanistic insights on how SARS-CoV-2 might influence the outcomes in cancer patients
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
The putative mechanistic insights on how SARS-CoV-2 might influence the outcomes in cancer patients
Deng, Jingwen ; Cai, Xiaopeng ; Chen, Zhi
Early evidence indicated that cancer patients are at increased risk of adverse outcomes and mortality after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. To determine the putative mechanism by which SARS-CoV-2 affects patients with cancers, we conducted a preliminary exploration at the molecular level. We collected differentially expressed proteins (DEPs) in the lung, liver, kidney, and thyroid of postmortem coronavirus disease 2019 (COVID-19) and non-COVID-19 patients [...]
Immunogenicity of two doses of inactive COVID-19 vaccine and third booster dose mRNA vaccine in patients with cancer receiving active systemic therapy
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Immunogenicity of two doses of inactive COVID-19 vaccine and third booster dose mRNA vaccine in patients with cancer receiving active systemic therapy
Guven, Deniz Can ; Gulbahce Incesu, Fatma Gul ; Yildirim, Hasan Cagri ; Erul, Enes ; Chalabiyev, Elvin ; Aktas, Burak Yasin ; Yuce, Deniz ; Arik, Zafer ; Kılıçkap, Saadettin ; Aksoy, Sercan ; Erman, Mustafa ; Hayran, Kadir Mutlu ; Unal, Serhat ; Alp, Alpaslan ; Dizdar, Ömer
We aimed to evaluate the seroconversion rates after two doses of inactive COVID-19 vaccine (CoronaVac) and the benefit of a third dose mRNA vaccine booster in patients with cancer receiving active treatment. Patients with solid tumors receiving active treatment (n=101) and patients with no-cancer (n=48) as the control group were included in the study. All the patients and controls had received two doses of CoronaVac and a third booster dose of the mRNA vaccine (Bnt162b2). Anti-SARS-CoV-2 Spike [...]
Immunogenicity of two doses of BNT162b2 and mRNA-1273 vaccines for solid cancer patients on treatment with or without a previous SARS-CoV-2 infection
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Immunogenicity of two doses of BNT162b2 and mRNA-1273 vaccines for solid cancer patients on treatment with or without a previous SARS-CoV-2 infection
La Verde, Nicla ; Riva, Agostino ; Cona, Maria Silvia ; Gabrieli, Arianna ; Cattaneo, Monica ; Fasola, Cinzia ; Lipari, Giuseppe ; De Stradis, Claudia ; Favorito, Valentina ; Lombardi Stocchetti, Benedetta ; Chizzoniti, Davide ; Covizzi, Alice ; Rulli, Eliana ; Galli, Francesca ; Ruggieri, Lorenzo ; Gambaro, Anna ; Ferrario, Sabrina ; Dalu, Davide ; Tarkowski, Maciej S.
Previous studies on the immunogenicity of SARS-CoV-2 mRNA vaccines showed a reduced seroconversion in cancer patients. The aim of this study is to evaluate the immunogenicity of two doses of mRNA vaccines in solid cancer patients with or without a previous exposure to the virus. This is a single-institution, prospective, non-randomized study. Patients in active treatment and a control cohort of healthy people received 2 doses of BNT162b2 (Comirnaty, BioNTech/Pfizer, USA) or mRNA-1273 (Spikevax, [...]
SARS CoV-2 virus in cancer patients: a new unknown in an unsolved equation
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
SARS CoV-2 virus in cancer patients: a new unknown in an unsolved equation
Martín, M. ; Vallejo, C. ; López-Campos, F. ; Quereda, C. ; Muñoz, T. ; Sánchez-Conde, M. ; Dominguez, J. A. ; Soriano, C. ; Suárez-Carantoña, C. ; Muriel, A. ; Garrido, P. ; Acero, J. ; Alvarez-Diaz, A. ; de la Pinta, C. ; Martínez-García, L. ; Hernánz, R. ; Fernández, E. ; Alarza, M. ; Hervás, A. ; Sancho, S.
Introduction: Cancer patients are more susceptible to infections and infection can be more severe than in patients without cancer diagnosis. We conducted this retrospective study in patients admitted for SARS-CoV-2 infection in order to find differences in inflammatory markers and mortality in cancer patients compared to others. Methods: We reviewed the electronic records of patients admitted for SARS-CoV-2 infection confirmed by PCR from March to September 2020. Data on socio-demographics, [...]
Breast Cancer Screening During the COVID-19 Pandemic: Moving from Disparities to Health Equity
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Breast Cancer Screening During the COVID-19 Pandemic: Moving from Disparities to Health Equity
Richman, Ilana ; Tessier-Sherman, Baylah ; Galusha, Deron ; Oladele, Carol R ; Wang, Karen
The COVID-19 pandemic created unprecedented disruptions to routine health care in the United States. Screening mammography, a cornerstone of breast cancer control and prevention, was completely halted in the spring of 2020, and screening programs have continued to face challenges with subsequent COVID-19 waves. Although screening mammography rates dropped for all women during the pandemic, a number of studies have now clearly documented that reductions in screening have been greater for some [...]
The impact of the COVID-19 pandemic on breast cancer screening and diagnosis in a Brazilian metropolitan area
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
The impact of the COVID-19 pandemic on breast cancer screening and diagnosis in a Brazilian metropolitan area
Solla Negrao, Erika Marina ; Cabello, Cesar ; Conz, Livia ; Mauad, Edmundo Carvalho ; Zeferino, Luiz Carlos ; Vale, Diama Bhadra
Objectives : To evaluate the performance of breast cancer screening and early diagnosis during the pandemic, compared to the pre-pandemic period. Setting: The public referral centre for screening in Campinas, São Paulo State, Brazil. Methods : This is an audit study of performance screening and diagnostic indicators. Two periods were analysed: 2019, the pre-COVID period, and 2020, the COVID period. All women who underwent mammography in these periods were included. Indicators were compared [...]
Financial toxicity and mental well-being of the oral cancer survivors residing in a developing country in the era of COVID 19 pandemic – A cross-se...
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Financial toxicity and mental well-being of the oral cancer survivors residing in a developing country in the era of COVID 19 pandemic – A cross-sectional study
Thaduri, Abhinav ; Garg, Pankaj.K. ; Malhotra, Manu ; Singh, Mahendra Pal ; Poonia, Dharma Ram ; Priya, Madhu ; Tyagi, Amit ; Kumar, Amit ; Bhardwaj, Abhishek ; Jat, Bhinyaram ; Panuganti, Achyuth ; Majumdar, Kinjal ; Usmani, Shahab ; singh, Vikramjit
OBJECTIVES : The primary outcome measures evaluated the financial toxicity and mental well-being of the oral cancer survivors. METHODS : A cross-sectional study of oral cancer survivors who were disease-free for more than six months after treatment and visited the hospital for a routine follow-up is included in the study. Mental well-being and financial toxicity were evaluated using the Depression, Anxiety, and Stress Scale - 21 (DASS 21) and Comprehensive Score for financial Toxicity (COST- [...]
Menée dans 7 pays européens à partir de données portant sur 42 361 patients ayant survécu au moins 5 ans à un cancer pédiatrique diagnostiqué entre 1940 et 2009 et couplée à une étude cas-témoins (1 000 témoins), cette étude analyse le risque d'insuffisance cardiaque et les facteurs associés
Risk Factors for Heart Failure Among Pan-European Childhood Cancer Survivors: A PanCareSurFup and ProCardio Cohort and Nested Case-Control Study
Menée dans 7 pays européens à partir de données portant sur 42 361 patients ayant survécu au moins 5 ans à un cancer pédiatrique diagnostiqué entre 1940 et 2009 et couplée à une étude cas-témoins (1 000 témoins), cette étude analyse le risque d'insuffisance cardiaque et les facteurs associés
Risk Factors for Heart Failure Among Pan-European Childhood Cancer Survivors: A PanCareSurFup and ProCardio Cohort and Nested Case-Control Study
Esmée C. de Baat ; Elizabeth A.M. Feijen ; Raoul C. Reulen ; Rodrigue S. Allodji ; Francesca Bagnasco ; Edit Bardi ; Fabiën N. Belle ; Julianne Byrne ; Elvira C. van Dalen ; Ghazi Debiche ; Ibrahima Diallo ; Desiree Grabow ; Lars Hjorth ; Momcilo Jankovic ; Claudia E. Kuehni ; Gill Levitt ; Damien Llanas ; Jacqueline Loonen ; Lorna Z. Zaletel ; Milena M. Maule ; Lucia Miligi ; Helena J.H. van der Pal ; Cécile M. Ronckers ; Carlotta Sacerdote ; Roderick Skinner ; Zsuzsanna Jakab ; Cristina Veres ; Nadia Haddy ; David L. Winter ; Florent de Vathaire ; Michael M. Hawkins ; Leontien C.M. Kremer
PURPOSE : Heart failure (HF) is a potentially life-threatening complication of treatment for childhood cancer. We evaluated the risk and risk factors for HF in a large European study of long-term survivors. Little is known of the effects of low doses of treatment, which is needed to improve current treatment protocols and surveillance guidelines. METHODS : This study includes the PanCareSurFup and ProCardio cohort of ≥ 5-year childhood cancer survivors diagnosed between 1940 and 2009 in seven [...]
Menée à partir de données portant sur un total de 1 748 patients atteints d'une tumeur solide, présentant des métastases osseuses et inclus dans deux études de cohortes prospectives, cette étude rétrospective analyse l'adhésion au traitement par dénosumab
Medication adherence with denosumab in patients with bone metastases from solid tumors treated in routine clinical settings: a retrospective study
Menée à partir de données portant sur un total de 1 748 patients atteints d'une tumeur solide, présentant des métastases osseuses et inclus dans deux études de cohortes prospectives, cette étude rétrospective analyse l'adhésion au traitement par dénosumab
Medication adherence with denosumab in patients with bone metastases from solid tumors treated in routine clinical settings: a retrospective study
Diel, Ingo J. ; Greil, Richard ; Janssen, Jan ; Kluike, Christian W. ; Behera, Bagmeet ; Abbasi, Ali ; Seesaghur, Anouchka ; Kellner, Michael ; Jaeger, Christine ; Bjorklof, Katja ; Tomova, Antoaneta ; Haslbauer, Ferdinand
Purpose : To describe (non)adherence with denosumab among patients with solid tumors and bone metastases. Methods : This retrospective, observational study pooled data from two completed prospective, multicenter cohort studies (X-TREME; Study 240) in adult patients with bone metastases from primary breast, prostate, lung, kidney, or other solid cancer types and administered denosumab 120 mg in routine clinical practice in Germany and Central and Eastern Europe. The studies were conducted [...]
Menée à partir des données GLOBOCAN portant sur 185 pays, cette étude présente une estimation, pour les années 2020 et 2040, de l'incidence du cancer colorectal et de la mortalité spécifique
Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN
Menée à partir des données GLOBOCAN portant sur 185 pays, cette étude présente une estimation, pour les années 2020 et 2040, de l'incidence du cancer colorectal et de la mortalité spécifique
Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN
Morgan, Eileen ; Arnold, Melina ; Gini, A ; Lorenzoni, V ; Cabasag, C J ; Laversanne, Mathieu ; Vignat, Jérôme ; Ferlay, Jacques ; Murphy, Neil ; Bray, Freddie
Objective : Colorectal cancer (CRC) is the third most common cancer worldwide. The geographical and temporal burden of this cancer provides insights into risk factor prevalence and progress in cancer control strategies. We examine the current and future burden of CRC in 185 countries in 2020 and 2040. Methods : Data on CRC cases and deaths were extracted from the GLOBOCAN database for the year 2020. Age-standardised incidence and mortality rates were calculated by sex, country, world region and [...]
Approches psycho-sociales (4)
Cet article américain décrit les axes de recherche du "National Cancer Institute" concernant l'utilisation et la qualité des soins dédiés aux patients atteints d'un cancer en insistant sur les risques sociaux, notamment l'évaluation de l'insécurité alimentaire, l'instabilité du logement et les obstacles liés au transport
National Cancer Institute-funded Social Risk Research in Cancer Care Delivery: Opportunities for Future Research
Cet article américain décrit les axes de recherche du "National Cancer Institute" concernant l'utilisation et la qualité des soins dédiés aux patients atteints d'un cancer en insistant sur les risques sociaux, notamment l'évaluation de l'insécurité alimentaire, l'instabilité du logement et les obstacles liés au transport
National Cancer Institute-funded Social Risk Research in Cancer Care Delivery: Opportunities for Future Research
Sanchez, Janeth I ; Adjei, Brenda A ; Randhawa, Gurvaneet ; Medel, Josh ; Doose, Michelle ; Oh, April ; Jacobsen, Paul B
Background : Cancer patients and survivors with food insecurity, housing instability, and transportation-related barriers face challenges in access and utilization of quality cancer care, thereby adversely impacting their health outcomes. This portfolio analysis synthesized and described National Cancer Institute (NCI)-supported social risk research focused on assessing food insecurity, housing instability, and transportation-related barriers among individuals diagnosed with cancer. Methods : [...]
Social Determinants of Health and Cancer Care—Where Do We Go from Here?
Cet article américain décrit les axes de recherche du "National Cancer Institute" concernant l'utilisation et la qualité des soins dédiés aux patients atteints d'un cancer en insistant sur les risques sociaux, notamment l'évaluation de l'insécurité alimentaire, l'instabilité du logement et les obstacles liés au transport
Social Determinants of Health and Cancer Care—Where Do We Go from Here?
Hughes Halbert, Chanita
Social determinants of health (SDOH) include the non-medical factors that contribute todisease risks and health care outcomes; social risk factors reflect these non-medical variables at an individual level. Now more than everand address social risk factors among patients to improve health care quality and outcomes. It is also anticipated that mitigating social risks in clinical settings will enhance equity among disparity populations. As a result, efforts are now being made to screen patients [...]
A partir d'une revue systématique de la littérature publiée entre 1980 et 2021 (31 études), cette étude analyse l'association entre l'accès à un logement stable et abordable, l'accès aux soins et la survie, chez des patients atteints d'un cancer
Housing and Cancer Care and Outcomes: A Systematic Review
A partir d'une revue systématique de la littérature publiée entre 1980 et 2021 (31 études), cette étude analyse l'association entre l'accès à un logement stable et abordable, l'accès aux soins et la survie, chez des patients atteints d'un cancer
Housing and Cancer Care and Outcomes: A Systematic Review
Fan, Qinjin ; Nogueira, Leticia ; Yabroff, K Robin ; Hussaini, S M Qasim ; Pollack, Craig E
Background : Access to stable and affordable housing is an important social determinant of health in the United States. However, research addressing housing and cancer care, diagnosis, and outcomes has not been synthesized. Methods : We conducted a systematic review of studies examining associations of housing and cancer care and outcomes using PubMed, Embase, Scopus, and CINAHL. Included studies were conducted in the United States and published in English between 1980 and 2021. Study [...]
Menée aux Etats-Unis auprès de 167 patiens âgés atteints d'un cancer et recevant des soins palliatifs à l'extérieur de l'hôpital (âge moyen : 65,9 ans), cette étude analyse les facteurs psychosociaux et physiques associés à leur anxiété et à leur détresse liées à la mort
Death Anxiety and Correlates in Cancer Patients Receiving Palliative Care
Menée aux Etats-Unis auprès de 167 patiens âgés atteints d'un cancer et recevant des soins palliatifs à l'extérieur de l'hôpital (âge moyen : 65,9 ans), cette étude analyse les facteurs psychosociaux et physiques associés à leur anxiété et à leur détresse liées à la mort
Death Anxiety and Correlates in Cancer Patients Receiving Palliative Care
Linda L. Emanuel, ; Sheldon Solomon, ; Harvey Max Chochinov, ; Marvin Omar Delgado Guay, ; George Handzo, ; Joshua Hauser, ; Sheri Kittelson, ; Sean O'Mahony, ; Tammie E. Quest, ; Michael W. Rabow, ; Tasha M. Schoppee, ; Diana J. Wilkie, ; Yingwei Yao, ; and George Fitchett
Background: Death anxiety is powerful, potentially contributes to suffering, and yet has to date not been extensively studied in the context of palliative care. Availability of a validated Death Anxiety and Distress Scale (DADDS) opens the opportunity to better assess and redress death anxiety in serious illness. Objective: We explored death anxiety/distress for associations with physical and psychosocial factors. Design: Ancillary to a randomized clinical trial (RCT) of Dignity Therapy (DT), [...]
Menée en Chine auprès de 285 parents d'enfants atteints d'un cancer et recevant un traitement anticancéreux, cette étude transversale analyse les facteurs associés à leur peur de la récidive de la maladie
Fear of progression and its associated factors in parents of children undergoing cancer treatment: a cross-sectional study
Menée en Chine auprès de 285 parents d'enfants atteints d'un cancer et recevant un traitement anticancéreux, cette étude transversale analyse les facteurs associés à leur peur de la récidive de la maladie
Fear of progression and its associated factors in parents of children undergoing cancer treatment: a cross-sectional study
Yang, Yiling ; Zhang, Yuwei ; Liang, Lichan ; Liao, Xiaomei ; Meng, Jiangnan ; Cai, Ruiqing ; Ye, Hongyu ; Hu, Jiamin ; He, Xiaofeng ; Shi, Lei
Objective : Fear of progression (FoP) is a common psychosocial problem among adult cancer patients, but data on parents of children undergoing cancer treatment are scarce. This study aimed to determine the prevalence of FoP in parents of children undergoing cancer treatment and explore the associated factors. Methods : Overall, 285 parents of children undergoing cancer treatment were recruited from three general hospitals in China. FoP in the parents was assessed using the Chinese version of [...]
Analyses économiques et systèmes de soins (3)
Menée dans un contexte espagnol, cette étude analyse le rapport coût-efficacité de NEPA, un traitement combinant des doses fixes de nétupitant et de palonosétron, pour prévenir les nausées et vomissements induits par une chimiothérapie hautement émétisante chez des patients atteints d'un cancer
Cost-effectiveness analysis of NEPA, a fixed-dose combination of netupitant and palonosetron, for the prevention of highly emetogenic chemotherapy-...
Menée dans un contexte espagnol, cette étude analyse le rapport coût-efficacité de NEPA, un traitement combinant des doses fixes de nétupitant et de palonosétron, pour prévenir les nausées et vomissements induits par une chimiothérapie hautement émétisante chez des patients atteints d'un cancer
Cost-effectiveness analysis of NEPA, a fixed-dose combination of netupitant and palonosetron, for the prevention of highly emetogenic chemotherapy-induced nausea and vomiting: an international perspective
Nilsson, Jonas ; Piovesana, Vittoria ; Turini, Marco ; Lezzi, Claudio ; Eriksson, Jennifer ; Aapro, Matti
Purpose : The aim of this study was to assess the cost-effectiveness of NEPA, a fixed-dose combination of oral netupitant (300 mg) and palonosetron (0.5 mg), compared to available treatments in Spain after aprepitant generic introduction in the market, and to discuss results in previously performed analyses in different wordwide settings. Methods : A Markov model including three health states, complete protection, complete response at best and incomplete response, was used to evaluate the [...]
Menée dans un contexte américain, cette étude analyse le rapport coût-efficacité de différentes stratégies thérapeutiques chez des patients atteints d'un cancer de la prostate à haut risque de récidive
Cost effectiveness of treatment strategies for high risk prostate cancer
Menée dans un contexte américain, cette étude analyse le rapport coût-efficacité de différentes stratégies thérapeutiques chez des patients atteints d'un cancer de la prostate à haut risque de récidive
Cost effectiveness of treatment strategies for high risk prostate cancer
Kowalchuk, Roman O. ; Kim, Hayeon ; Harmsen, William S. ; Jeans, Elizabeth B. ; Morris, Lindsay K. ; Mullikin, Trey C. ; Miller, Robert C. ; Wong, William W. ; Vargas, Carlos E. ; Trifiletti, Daniel M. ; Phillips, Ryan M. ; Choo, C. R. ; Davis, Brian J. ; Beriwal, Sushil ; Tendulkar, Rahul D. ; Stish, Bradley J. ; Breen, William G. ; Waddle, Mark R.
Background : Patients with high-risk prostate cancer (HRPC) have multiple accepted treatment options. Because there is no overall survival benefit of one option over another, appropriate treatment must consider patient life expectancy, quality of life, and cost. Methods : The authors compared quality-adjusted life years (QALYs) and cost effectiveness among treatment options for HRPC using a Markov model with three treatment arms: (1) external-beam radiotherapy (EBRT) delivered with 20 [...]
Menée dans un contexte américain, cette étude compare le rapport coût-efficacité de trois stratégies thérapeutiques utilisant un agent chimiothérapeutique en monothérapie chez des patientes atteintes d'un cancer du sein triple négatif de stade métastatique ou réfractaire à une thérapie endocrinienne
Cost-Effectiveness of Pharmacologic Treatment Options for Women With Endocrine-Refractory or Triple-Negative Metastatic Breast Cancer
Menée dans un contexte américain, cette étude compare le rapport coût-efficacité de trois stratégies thérapeutiques utilisant un agent chimiothérapeutique en monothérapie chez des patientes atteintes d'un cancer du sein triple négatif de stade métastatique ou réfractaire à une thérapie endocrinienne
Cost-Effectiveness of Pharmacologic Treatment Options for Women With Endocrine-Refractory or Triple-Negative Metastatic Breast Cancer
Stephanie B. Wheeler ; Jason Rotter ; Anagha Gogate ; Katherine E. Reeder-Hayes ; Sarah W. Drier ; Donatus U. Ekwueme ; Temeika L. Fairley ; Gabrielle B. Rocque ; Justin G. Trogdon
PURPOSE : Treatments for endocrine-refractory or triple-negative metastatic breast cancer (mBC) are modestly effective at prolonging life and improving quality of life but can be extremely expensive. Given these tradeoffs in quality of life and cost, the optimal choice of treatment sequencing is unclear. Cost-effectiveness analysis can explicitly quantify such tradeoffs, enabling more informed decision making. Our objective was to estimate the societal cost-effectiveness of different [...]
Economic Analysis of Screening, Diagnostic, and Treatment Technologies for Cancer: Reflections and a Roadmap for Prospective Authors
Menée dans un contexte américain, cette étude compare le rapport coût-efficacité de trois stratégies thérapeutiques utilisant un agent chimiothérapeutique en monothérapie chez des patientes atteintes d'un cancer du sein triple négatif de stade métastatique ou réfractaire à une thérapie endocrinienne
Economic Analysis of Screening, Diagnostic, and Treatment Technologies for Cancer: Reflections and a Roadmap for Prospective Authors
Scott D. Ramsey ; Jonathan W. Friedberg ; John V. Cox ; Jeffrey M. Peppercorn
Policy proposals addressing the high cost of treating cancer are among the most persistently controversial topics in oncology. The rising national economic burden of cancer in an aging population, combined with skyrocketing costs for cancer diagnostics, therapies, and hospital-based care, all strain patient, family, and health system budgets.1 Few would disagree with the sentiment that controlling the rate of spending growth is fundamental and essential for societies wishing to improve access [...]
Sensibilisation et communication (1)
Menée aux Etats-Unis par enquête auprès de 150 parents d'enfants atteints d'un cancer, cette étude analyse l'évolution de leurs relations avec les professionnels de santé (médecins oncologues, infirmières cliniciennes) durant la première année suivant le diagnostic
Change in the Parent-Clinician Relationship Throughout the First Year of Treatment in Pediatric Oncology
Menée aux Etats-Unis par enquête auprès de 150 parents d'enfants atteints d'un cancer, cette étude analyse l'évolution de leurs relations avec les professionnels de santé (médecins oncologues, infirmières cliniciennes) durant la première année suivant le diagnostic
Change in the Parent-Clinician Relationship Throughout the First Year of Treatment in Pediatric Oncology
Mack, Jennifer W. ; Jaung, Tim ; Uno, Hajime ; Brackett, Julienne
Importance : Challenges in the therapeutic relationship between clinicians and parents of children with cancer have been shown to emerge immediately after diagnosis, but little is known about whether such relationships improve over time. Objective : To better understand the potential evolution of parent-clinician relationships over the first year after diagnosis of pediatric cancer. Design, Setting, and Participants :This survey study was conducted from November 2015 to September 2020 at [...]
Soins palliatifs (1)
Menée aux Pays-Bas à partir de données portant sur un total de 850 patients décédés d'un cancer de stade avancé entre 2014 et 2016, cette étude analyse l'effet, sur l'utilisation des outils de diagnostic, sur les traitements et sur les interventions médicales, de soins palliatifs standardisés durant les 3 derniers mois de vie
The effect of a palliative care pathway on medical interventions at the end of life: a pre-post-implementation study
Menée aux Pays-Bas à partir de données portant sur un total de 850 patients décédés d'un cancer de stade avancé entre 2014 et 2016, cette étude analyse l'effet, sur l'utilisation des outils de diagnostic, sur les traitements et sur les interventions médicales, de soins palliatifs standardisés durant les 3 derniers mois de vie
The effect of a palliative care pathway on medical interventions at the end of life: a pre-post-implementation study
van der Padt-Pruijsten, Annemieke ; Leys, Maria B. L. ; Hoop, Esther Oomen-de ; van der Heide, Agnes ; van der Rijt, Carin C. D.
Purpose : Adequate integration of palliative care in oncological care can improve the quality of life in patients with advanced cancer. Whether such integration affects the use of diagnostic procedures and medical interventions has not been studied extensively. We investigated the effect of the implementation of a standardized palliative care pathway in a hospital on the use of diagnostic procedures, anticancer treatment, and other medical interventions in patients with incurable cancer at the [...]